These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
597 related articles for article (PubMed ID: 27887627)
1. EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma. Chen X; Wang X; Wei X; Wang J J Ovarian Res; 2016 Nov; 9(1):83. PubMed ID: 27887627 [TBL] [Abstract][Full Text] [Related]
2. Expression of EphB6 in ovarian serous carcinoma is associated with grade, TNM stage and survival. Gu Y; Li F; Qian N; Chen X; Wang H; Wang J J Clin Pathol; 2016 May; 69(5):448-53. PubMed ID: 26468391 [TBL] [Abstract][Full Text] [Related]
3. EphB3 protein is associated with histological grade and FIGO stage in ovarian serous carcinomas. Gao W; Zhang Q; Wang Y; Wang J; Zhang S APMIS; 2017 Feb; 125(2):122-127. PubMed ID: 28120491 [TBL] [Abstract][Full Text] [Related]
4. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors]. Wen J; Shi JL; Shen DH; Chen YX; Song QJ Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451 [TBL] [Abstract][Full Text] [Related]
5. PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis. Wang H; Li G; Yin Y; Wang J; Wang H; Wei W; Guo Q; Ma H; Shi Q; Zhou X; Wang J Int J Clin Exp Pathol; 2014; 7(11):7881-9. PubMed ID: 25550828 [TBL] [Abstract][Full Text] [Related]
6. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma. Cui X; Li L; Yan G; Meng K; Lin Z; Nan Y; Jin G; Li C BMC Cancer; 2015 Apr; 15():244. PubMed ID: 25885439 [TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas]. Shao HL; Shen DH; Xue WC; Li Y; Yu YZ Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760 [TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma. Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277 [TBL] [Abstract][Full Text] [Related]
9. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma. Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275 [TBL] [Abstract][Full Text] [Related]
10. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma]. Xiang L; Li J; Wang LJ; Zheng WX; Kong BH Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344 [TBL] [Abstract][Full Text] [Related]
11. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors]. Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of β-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas. Wang H; Wang H; Makki MS; Wen J; Dai Y; Shi Q; Liu Q; Zhou X; Wang J Int J Clin Exp Pathol; 2014; 7(1):264-71. PubMed ID: 24427347 [TBL] [Abstract][Full Text] [Related]
13. PDK1 is Expressed in Ovarian Serous Carcinoma and Correlates with Improved Survival in High-grade Tumors. Lohneis P; Darb-Esfahani S; Dietel M; Braicu I; Sehouli J; Arsenic R Anticancer Res; 2015 Nov; 35(11):6329-34. PubMed ID: 26504072 [TBL] [Abstract][Full Text] [Related]
14. FGF18 as a potential biomarker in serous and mucinous ovarian tumors. El-Gendi S; Abdelzaher E; Mostafa MF; Sheasha GA Tumour Biol; 2016 Mar; 37(3):3173-83. PubMed ID: 26427667 [TBL] [Abstract][Full Text] [Related]
15. The potential prognostic value of cathepsin D protein in serous ovarian cancer. Chai Y; Wu W; Zhou C; Zhou J Arch Gynecol Obstet; 2012 Aug; 286(2):465-71. PubMed ID: 22476353 [TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic study and immunohistochemistry comparison of Pax2, p53 and Ki-67 in low- and high-grade ovarian serous carcinomas]. Shen XX; Yu L; Bi R; Yang WT Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):511-6. PubMed ID: 22169637 [TBL] [Abstract][Full Text] [Related]
17. Decreased Eph receptor‑A1 expression is related to grade in ovarian serous carcinoma. Jin Y; Zou Y; Wan L; Lu M; Liu Y; Huang G; Wang J; Xi Q Mol Med Rep; 2018 Apr; 17(4):5409-5415. PubMed ID: 29393455 [TBL] [Abstract][Full Text] [Related]
18. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma]. Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343 [TBL] [Abstract][Full Text] [Related]
19. Glycodelin in ovarian serous carcinoma: association with differentiation and survival. Mandelin E; Lassus H; Seppälä M; Leminen A; Gustafsson JA; Cheng G; Bützow R; Koistinen R Cancer Res; 2003 Oct; 63(19):6258-64. PubMed ID: 14559812 [TBL] [Abstract][Full Text] [Related]
20. Expression of PH Domain Leucine-rich Repeat Protein Phosphatase, Forkhead Homeobox Type O 3a and RAD51, and their Relationships with Clinicopathologic Features and Prognosis in Ovarian Serous Adenocarcinoma. Zhang J; Wang JC; Li YH; Wang RX; Fan XM Chin Med J (Engl); 2017 Feb; 130(3):280-287. PubMed ID: 28139510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]